1. Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms;Kluetz;Clin Cancer Res,2016
2. Symptom burden in the first year after cancer diagnosis: an analysis of patient-reported outcomes;Bubis;J Clin Orthod,2018
3. European Medicines Agency. Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man: the use of patient-reported outcome (PRO) measures in oncology studies,2016
4. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims clinical/medical guidance for industry patient-reported outcome measures: use in medical product development to support;Fax;Labeling Claims,2009
5. A review of patient-reported outcomes labeling for oncology drugs approved by the FDA and the EMA (2012-2016);Gnanasakthy;Value Health,2019